ast-3424
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 3, 2019 (NCT06239155)
Timeline
Indications
Mechanism of action
- DNADEGRADER
DNA degrader
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07310173 | Phase 2 | Jan 1, 2026 | Zhejiang Hisun Pharmaceutical Co. Ltd. |
| NCT06239155 | Phase 1/Phase 2 (Phase 2) | Sep 3, 2019 | Ascentawits Pharmaceuticals, Ltd, Huazhong University of Science and Technology |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ascentawits Pharmaceuticals, Ltd | For profit | 1 | 1 | 1 | 2019 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Zhejiang Hisun Pharmaceutical Co. Ltd. | For profit | 1 | 1 | 1 | 2026 |
3 organizations
Page 1 / 1